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Abstract
Background: Neuronal hyperexcitability and hypersynchrony have been described as key features of
neurophysiological dysfunctions in the Alzheimer’s disease (AD) continuum. Conversely, physical activity (PA) has
been associated with improved brain health and reduced AD risk. However, there is controversy regarding whether
AD genetic risk (in terms of APOE ε4 carriage) modulates these relationships. The utilization of multiple outcome
measures within one sample may strengthen our understanding of this complex phenomenon.
Method: The relationship between PA and functional connectivity (FC) was examined in a sample of 107 healthy
older adults using magnetoencephalography. Additionally, we explored whether ε4 carriage modulates this
association. The correlation between FC and brain structural integrity, cognition, and mood was also investigated.
Results: A relationship between higher PA and decreased FC (hyposynchrony) in the left temporal lobe was
observed among all individuals (across the whole sample, in ε4 carriers, and in ε4 non-carriers), but its effects
manifest differently according to genetic risk. In ε4 carriers, we report an association between this region-specific FC
profile and preserved brain structure (greater gray matter volumes and higher integrity of white matter tracts). In
this group, decreased FC also correlated with reduced anxiety levels. In ε4 non-carriers, this profile is associated
with improved cognition (working and episodic memory).
Conclusions: PA could mitigate the increase in FC (hypersynchronization) that characterizes preclinical AD, being
beneficial for all individuals, especially ε4 carriers.
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Background
Physical activity (PA) has been persistently referred to
as the twenty-first century panacea. In both clinical
and non-clinical populations, PA is related to im-
provements in sleep quality, mood, cognitive perform-
ance, and perceived quality of life [1]. In addition, PA
is associated with marked decreases in the risk of a
broad spectrum of diseases, including diabetes melli-
tus, cancer, and dementia [1]. In the specific case of
Alzheimer’s disease (AD; the most common form of
dementia), PA has been found to reduce incidence,
AD-associated neuropathological burden, and cogni-
tive decline [2–4].
The major genetic risk factor for sporadic AD,
namely the apolipoprotein E (APOE) ε4 allele, is
present in 60–80% of AD cases and is linked to a
3.2-fold increased AD risk in heterozygosis and up to
14.9-fold increased AD risk in homozygosis [5]. While
most studies claim that PA-protective effects mainly
manifest among ε4 carriers [6, 7], others identified
this same effect exists only in non-carriers [8, 9],
while other studies report benefits regardless of APOE
ε4 allele carriage [10, 11]. This inconsistent literature
is likely due to the use of varying study designs and
outcome measures (i.e., hippocampal volume, short-
term memory, or rate of AD conversion). To further
understand the modulating effect of AD genetic risk
on the relationship between PA and brain health, a
more detailed investigation using varied outcome
measures is warranted.
Based on the inconsistencies in previous literature, the
current study will first investigate the relationship be-
tween PA and synaptic activity in cognitively healthy
older adults. Synaptic activity will be captured employing
magnetoencephalography and analyzed under the frame-
work of network synchronization. It is believed that the
flow of information between different brain regions is
sustained by synchronous changes in the frequency, pat-
tern, or strength of their oscillatory activity [12]. Early
loss of inhibitory neurons in preclinical AD leads to a
state of increased hyperexcitability and hypersynchrony
[13–15], which has been found to augment amyloid re-
lease and produce neurotoxic effects [16, 17]. We
hypothesize that PA exerts a neuroprotective effect that
will be associated with reduced network synchrony in
both groups, in opposition to the state of synaptic hyper-
excitability that characterizes preclinical and prodromal
AD [18–22]. Then, once we have identified the func-
tional connectivity (FC) patterns that are influenced by
PA level, we will explore if there are any associations be-
tween these FC patterns and structural integrity (gray
and white matter), cognition, and mood. Additionally,




A total of 262 individuals participated in a study aimed to
characterize the neurophysiological features of healthy
aging. Participants were recruited from local hospitals and
through several dissemination talks, and a team of expert
neuropsychologists assessed that they met inclusion cri-
teria. A detailed list of exclusion criteria can be found in
[23]. The procedure was performed following current
guidelines and regulations, and the study was approved by
the Hospital Universitario San Carlos Ethics Committee.
Every participant signed an informed consent.
We included participants who had available data re-
garding our main variables of interest (n = 158; Mini-
Mental State Examination (MMSE) score, genetic infor-
mation, and validated magnetic resonance imaging
(MRI), MEG, and actigraphy data). We then excluded
anyone with an MMSE score less than 26 (n = 5), aged
less than 50 years (n = 8), and participants carrying less
frequent APOE genotypes (ε2ε3, n = 11; ε2ε4, n = 1;
ε4ε4, n = 7; there were no ε2ε2 homozygotes in the ori-
ginal cohort). We focused on the comparison between
individuals at standard genetic risk for AD (ε3ε3; here-
after non-carriers) and individuals at increased genetic
risk for AD in heterozygosis (ε3ε4; hereafter; carriers)
since sample sizes were insufficient to separately study
the effects ε2 carriage (linked to reduced risk of AD but
increased risk of type III hyperlipoproteinemia [24]) and
ε4 carriage in homozygosis. Nevertheless, excluded ge-
notypes are known to alter molecular and cellular dy-
namics [24, 25], which could potentially interfere with
the neurophysiological response to exercise, and there-
fore, we decided not to group together all ε4-carrying
(ε2ε4, ε3ε4, ε4ε4) and all ε4-non-carrying (ε2ε2, ε2ε3,
ε3ε3) genotypes. Among the remaining 127 participants,
there were 36 APOE ε4 carriers and 91 non-carriers. We
carefully selected 33 APOE ε4 carriers and 74 non-
carriers so that both subsamples would match in PA
levels (TPA and MVPA), age, sex, educational level,
MMSE, and body mass index. There were two main rea-
sons to match the sample according to all these relevant
variables instead of using them as covariates in subse-
quent analyses. First, including several covariates in a
cluster-based permutation test could have introduced a
methodological pitfall in the permutation procedure.
Second, using covariates only controls for linear influ-
ences on the data, dismissing any other possible non-
linear confound.
The final sample was composed of 107 healthy older
adults, aged 50–82 years. A detailed list of the sample
characteristics can be found in Table 1, including scores
extracted from the neuropsychological tests: Geriatric
Depression Scale [26], the anxiety subscale from the
Goldberg Anxiety and Depression Inventory [27], and
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the Digit Span Forward, Digit Span Backward, and Lo-
gical Memory II (delayed recall, units, and gist) subscales
from the Weschler Adult Intelligence Scale IV (WAIS-
IV, [28]).
Physical activity measurement
For PA measurement, we used the ActiGraph GT3X+
accelerometer (LLC, Pensacola, FL). Participants were
requested to wear the accelerometers on their right hip
for 7 complete days, taking them off only during water-
based activities [29, 30]. For cleaning and processing the
data, we used the ActiLife software (6.13.3) (LLC, Pensa-
cola, FL). The validation criteria required each individual
to wear the accelerometer during at least 3 weekdays
and 1 weekend day for a minimum of 10 h per day [30].
We considered ≥ 60min of continuous zeroes while
allowing for up to 2 min of counts ≤ 100 counts as non-
wear time [31]. To classify the PA, we categorized seden-
tary time as < 100 counts/min, light activity as 100–1951
counts/min, and moderate to vigorous physical activity
(MVPA) as ≥ 1952 counts/min [32].
In this study, two different measures of PA were incor-
porated: Total Time In Freedson Bouts, which is a stan-
dardized measure of PA volumes (total PA, TPA), and
daily average of MVPA. TPA was normalized by total
wear time.
APOE genotyping
As described in [23], we obtained genomic DNA from 10
ml blood samples in ethylenediaminetetraacetic acid
(EDTA). Employing TaqMan assays on an Applied Biosys-
tems 7500 Fast Real Time PCR machine (Applied Biosys-
tems, Foster City, CA), single nucleotide polymorphisms
(SNPs) rs7412 and rs429358 genotypes were determined.
APOE genotype was established accordingly. In this study,
only ε3ε3 and ε3ε4 individuals were considered.
MRI acquisition and volumetric analyses
To generate the T1-weighted MRI images from each
participant, a General Electric 1.5-T system was
employed. We applied a high-resolution antenna and a
homogenization PURE filter (Fast Spoiled Gradient Echo
Table 1 Descriptive measures of the final sample
Variable Whole sample Carriers Non-carriers p value
Sex (M; F) 32; 75 8; 25 24; 50 0.49
Age 60.48 ± 8.10 59.36 ± 7.46 60.97 ± 8.36 0.39
Education 4.62 ± 0.68 4.61 ± 0.75 4.622 ± 0.63 0.86
MMSE 29.26 ± 0.84 29.33 ± 0.89 29.23 ± 0.82 0.42
BMI 25.03 ± 3.61 25.01 ± 3.82 25.04 ± 3.55 0.90
TPA 0.0125 ± 0.0117 0.0109 ± 0.0107 0.0133 ± 0.0122 0.48
MVPA 36.34 ± 21.12 33.12 ± 17.64 37.77 ± 22.47 0.54
Forward digits 5.95 ± 1.22 5.88 ± 1.22 5.99 + 1.23 0.75
Reverse digits 4.50 ± 1.36 4.67 ± 1.65 4.43 ± 1.22 0.55
Logical mem. units 18.79 ± 11.13 20.97 ± 11.87 17.86 ± 10.76 0.25
Logical mem. gist 15.74 ± 10.87 13.69 ± 8.14 16.63 ± 11.80 0.52
Anxiety 1.71 ± 0.84 1.86 ± 2.37 1.65 ± 2.05 0.84
Depression 1.24 ± 1.62 1.27 ± 1.44 1.23 ± 1.70 0.70
Total GM 545,939 ± 51,206 546,825 ± 66,891 545,538 ± 42,833 0.80
Hippocampus 7549 ± 834 7583 ± 954 7533 ± 780 0.81
Amygdala 2730 ± 470 2721 ± 573 2734 ± 420 0.51
Precuneus 16,337 ± 2002 16,403 ± 2491 16,306.83 ± 1757 0.87
Global FA 0.4355 ± 0.017362 0.4395 ± 0.01645 0.4336 ± 0.0176 0.11
Uncinate 0.4378 ± 0.0238 0.4387 ± 0.0232 0.4374 ± 0,0242 0.87
Parahippocampus 0.4355 ± 0.0173 0.4177 ± 0.0315 0.4145 ± 0.0289 0.71
Mean values ± standard deviation for all matching variables as well as variables used for correlation analyses. These include sex (where M stands for male and F
for female); age (in years); education (in terms of educational level on a 0—illiterate—to 5—postsecondary education—scale); Mini-Mental State Examination
(MMSE); body mass index (BMI); total physical activity (TPA, normalized by actigraphy wear time); daily average of moderate to vigorous physical activity (MVPA, in
minutes); working memory (Forward and Reverse Digit Span—forward and reverse digits); episodic memory (Logical Memory II—delayed recall; for units and
gist—logical mem. units and gist); anxiety (Goldberg’s test); depression (Geriatric Depression Scale); total gray matter volume (GM, in cubic millimeter);
hippocampus, amygdala, and precuneus volumes (left plus right, in cubic millimeter); global fractional anisotropy (FA); and uncinate and parahippocampal
fasciculus fractional anisotropy (left and right weighted arithmetic mean). Results are displayed for the whole sample and also for each subsample of interest
(APOE ε4 carriers and non-carriers). p values for the Mann-Whitney and Fisher (sex) tests are also shown. No significant between-group differences arose across
all comparisons
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sequence, TR/TE/TI = 11.2/4.2/450 ms; flip angle 12°; 1
mm slice thickness, 256 × 256 matrix, and FOV 25 cm).
The resulting images were processed using the Free-
surfer software (version 5.1.0) and its specialized tool for
automated cortical parcellation and subcortical segmen-
tation [33]. The measures that were included in further
analyses were total gray matter, amygdala, precuneus,
and hippocampus (in cubic millimeter). The volumes of
bilateral structures were collapsed in order to obtain a
single measure for each region.
Diffusion tensor imaging
Data acquisition
The same General Electric 1.5-T magnetic resonance
scanner was also used to collect diffusion-weighted im-
ages (DWI). The acquisition parameters for DWI were
as follows: TE/TR 96.1/12,000ms; NEX 3 for increasing
the SNR; 2.4 mm slice thickness, 128 × 128 matrix, and
30.7 cm FOV yielding an isotropic voxel of 2.4 mm; 1
image with no diffusion sensitization (i.e., T2-weighted
b0 images); and 25 DWI (b = 900 s/mm2). Data were re-
corded with a single shot echo planar imaging sequence.
Preprocessing
DWI images were processed following the procedure
previously published in [34]. Probabilistic fiber tractogra-
phy was run on the automated tool AutoPtx (https://fsl.
fmrib.ox.ac.uk/fsl/fslwiki/AutoPtx) as reported in [34].
Two bilateral tracts were later used for correlation ana-
lyses: the uncinate and the parahippocampal fasciculi. In
order to reduce the number of tests, the weighted arith-
metic mean of left and right structures was used. Like-
wise, a measure of global fractional anisotropy (FA) was
calculated averaging all 27 original tracts provided by
the system.
Magnetoencephalography
Data acquisition and signal preprocessing
MEG data was recorded using a 306-channel whole-
head MEG system (Vectorview, ElektaNeuromag,
Finland), placed in a magnetically shielded room at the
Center for Biomedical Technology in Madrid, following
the protocol described in [23].
Raw data were first submitted to the Maxfilter soft-
ware to remove external noise [35]. Fieldtrip software
[36] was used to automatically scan MEG data for arti-
facts, which were visually confirmed by an MEG expert.
Artifact-free data were segmented in 4 s epochs. Then,
MEG time series were filtered into delta (2–4 Hz), theta
(4–8 Hz), alpha (8–12 Hz), and beta (12–30 Hz). This
procedure has been reported in detail in [22].
Source reconstruction and connectivity analyses
We used a regular 1-cm grid in the Montreal Neuro-
logical Institute (MNI) template. The resulting model
comprised 2459 sources distributed across the brain,
which were transformed to each subject’s space follow-
ing the methodology detailed in [22].
We used phase locking value (PLV) to calculate func-
tional connectivity. The Automated Anatomical Labeling
atlas (AAL, [37]) was applied to segment the source tem-
plate with 2459 nodes excluding the cerebellum, basal
ganglia, thalamus, and olfactory cortices. The resulting
78 regions of interest included 1202 nodes. Symmetrical
whole-brain matrices of 1202 × 1202 nodes were ob-
tained by averaging PLV values across trials for each
participant and frequency band. Each node’s strength
was computed by averaging its corresponding FC with
the whole grid. Such averaging resulted in a source-
reconstructed FC matrix of 1202 nodes by 4 frequency
bands by 107 participants.
Statistical analyses
Functional connectivity strength clustering
Network-based statistics (NBS) were carried out for each
frequency band [38]. Clusters consisted of several
spatially adjacent nodes that presented a significant par-
tial correlation (age as covariate) between functional
connectivity strength (FC-st) values and each PA vari-
able (Spearman’s correlation, p < 0.01). To form a clus-
ter, the correlation coefficients of all nodes within the
cluster were required to have the same sign. Only clus-
ters including at least 1% of the grid (i.e., a minimum of
12 nodes) were considered (i.e., minimum size condi-
tion). Spearman’s rho values were Fisher Z-transformed.
Cluster-mass statistics were computed as the sum of all
Z values corresponding with all nodes within each clus-
ter. Moderation analyses were carried out to study the
possible influence exerted by APOE genotype (ε4 carriers
vs non-carriers) in the reported relationship between
FC-st and TPA. We employed multiple regression ana-
lysis and calculated the increase in variance explained by
our model after including the interaction term (APOE_
by_TPA). This model first used TPA and APOE as pre-
dictors to linearly estimate FC-st in the significant clus-
ter. Then, the interaction term was added (TPA_by_
APOE). The p value for this interaction term is inter-
preted as the moderating effect significance.
Controlling for multiple comparisons
To control for multiple comparisons, the whole process
was repeated 5000 times, shuffling the correspondence
between FC-st and each PA measure across all partici-
pants. At each repetition, the maximum surrogate clus-
ter’s statistic was kept creating a maximal null
permutation distribution. For each main cluster, cluster-
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mass statistics in the original and the randomized data-
sets were compared. In NBS, p value represents the pro-
portion of the permutation distribution with cluster-
mass statistic values greater or equal than the cluster-
mass statistic value of the original data. Only clusters
which survived NBS (permutation p value < 0.05) were
considered in further analyses. For each main cluster,
FC-st values were averaged across all nodes to obtain
cluster’s representative MEG markers.
Correlations between FC-st and markers of brain function
and structure
These markers were used in subsequent correlation ana-
lyses with measures of specific AD signatures (the
complete list is shown in Table 4). These were carried
out taking the whole sample and following stratification
of the cohort by APOE ε4 carriers and non-carriers. p
values were corrected using false discovery rate (FDR) to
account for multiple testing. All statistical analyses were
carried out using MATLAB R2018b (Mathworks Inc).
Seed-based analyses
In order to examine whether the FC-st results were
caused by global or between-region-specific effects, we
performed corresponding seed analysis, using the previ-
ous clusters as seeds. The FC values assessed were the
average FC between each node of the grid and corre-
sponding cluster’s nodes. Then, a set of partial correl-
ation (age as covariate) between these FC values and
each PA variable (Spearman’s correlation, p < 0.01) were
computed. Only clusters that did not overlap with the
original seed cluster were reported in this study.
Results
Physical activity is associated with decreased temporal
lobe FC-st in ε4 carriers and non-carriers
FC-st is computed as the average FC between each spe-
cific source and the rest of the network. Here, we exam-
ined whether any brain regions, henceforth referred to
as clusters, had FC-st values that significantly correlated
with PA levels, using age as a covariate. Significant clus-
ters comprised brain regions that behave as functional
units.
Applying NBS methodology independently for each
frequency band, three significant clusters emerged, lo-
cated mainly on the left temporal lobe (see Table 2).
Using TPA, we found two significant main (m) clusters,
one in the theta band (mθTPA, Fig. 1) and one in the
delta band (mδTPA, Fig. 2a). In the case of MVPA, only
one cluster in the delta band showed a significant correl-
ation with FC-st (mδMVPA). Since mδTPA and
mδMVPA overlapped to a great degree, only mδTPA is
depicted in Fig. 2. In the three clusters, FC-st negatively
correlated with PA; thus, higher levels of PA were asso-
ciated with lower cluster FC-st. In addition, the correl-
ation between PA and FC-st in both delta band clusters
remained significant when looking at the APOE ε4 car-
rier and non-carrier groups separately. The cluster in
the theta band was significant among APOE ε4 carriers;
however, within the APOE ε4 non-carriers, the
Table 2 Main clusters presenting decreased FC-st at higher PA levels
Cluster mθTPA mδTPA mδMVPA
ROIs Left amygdala (100%) Left amygdala (100%) Left fusiform gyrus (13.3%)
Left hippocampus (20%) Left fusiform gyrus (13.3%) Left inferior frontal gyrus, orbital (33.3%)
Left inferior frontal gyrus, orbital (8.3%) Left inferior frontal gyrus, orbital (41.7%) Left inferior temporal gyrus (16.7%)
Left inferior temporal gyrus (4.2%) Left inferior frontal gyrus, opercular (28.6%) Left insula (50%)
Left insula (50%) Left inferior temporal gyrus (12.5%) Left middle temporal gyrus (13.6%)
Left middle temporal gyrus (15.9%) Left insula (71.4%) Left temporal pole, middle temporal gyrus
(85.7%)
Left postcentral gyrus (2.9%) Left middle temporal gyrus (27.3%) Left temporal pole, superior temporal gyrus
(70%)
Left superior temporal gyrus (50%) Left parahippocampus (25%) Left superior temporal gyrus (15%)
Left temporal pole, middle temporal gyrus
(28.6%)
Left postcentral gyrus (11.8%)
Left temporal pole, superior temporal gyrus
(40%)
Left rolandic operculum (40%)
Left superior temporal gyrus (45%)
Left temporal pole, middle temporal gyrus
(85.7%)
Left temporal pole, superior temporal gyrus
(70%)
Total physical activity (TPA) and daily average of moderate to vigorous physical activity (MVPA) correlated with functional connectivity strength (FC-st) in three
main clusters. The list of regions of interest (ROIs) upon each significant main cluster fall is shown (in alphabetical order). The percentage of each ROI captured by
each cluster is presented in brackets
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relationship was not significant. To further assess these
potential interaction effects, we conducted a moderation
analysis. We observed a significant moderation effect of
APOE genotype for the mθTPA cluster (p = 0.044) while
no significant effect was observed for mδTPA (p = 0.13)
nor mδMVPA (p = 0.055).
Within the current study, greater levels of PA are asso-
ciated with lower left temporal functional connectivity in
both APOE ε4 carriers and non-carriers. Our findings
are relevant to AD risk, as prodromal AD is usually
characterized, in low frequency bands, as a stage of tem-
poral lobe hyperexcitability [18–22].
Decreased left temporal FC-st is mainly driven by reduced
temporo-occipital and temporo-frontal FC
Decreased cluster FC-st indicates that the oscillatory ac-
tivity (within a given frequency band) of the cluster re-
gions is less synchronously paired with activity from all
across the brain. However, in order to more specifically
identify which connections drove such an effect, we per-
formed a seed-based analysis. In this seed-based correl-
ation analysis, we identified the specific connections
(secondary clusters) of each of the main clusters with
the rest of the brain that were significantly modulated by
PA. We found two significant secondary (s) clusters for
each main cluster in the delta band (s1δTPA and
s2δTPA for mδTPA, Fig. 2b, c, respectively, and
s1δMVPA and s2δMVPA for mδMVPA). The detailed
list of areas belonging to these clusters is shown in
Table 3. This result was significant among the whole
sample and both APOE ε4 carriage subgroups. No sig-
nificant secondary clusters emerged for mθTPA.
Lower temporal lobe FC is differently associated with
cognitive function and brain structure in APOE ε4 carriers
and non-carriers
Once we had described how greater levels of PA related
to a distinctive FC-st profile, we aimed to characterize
the relationship between this profile and parameters of
brain health in order to better understand our results.
Significant correlations were quite consistent across
clusters. In the whole sample, most AD markers nega-
tively correlated with FC-st, so that lower FC-st values
were associated with healthier scores over different do-
mains. Additionally, structural measures (total gray mat-
ter, hippocampus, precuneus, and amygdala volumes, as
well as parahippocampal fasciculus fractional anyso-
tropy) were significantly negatively associated with FC-st
among APOE ε4 carriers. Anxiety levels also significantly
correlated with FC-st in this group, so that lower FC-st
was associated with lower anxiety levels. In contrast,
only a few significant correlations were found in APOE
ε4 non-carriers, all of them related to cognition (working
and episodic memory). The complete set of correlation
results can be found in Table 4.
Discussion
The purpose of the current study was to deepen our un-
derstanding of the role that APOE ε4 plays as a modula-
tor in the relationship between PA and brain structure
and function. The most relevant finding of the present
work is that greater engagement in PA is related to
lower left temporal FC, both in APOE ε4 carriers and
non-carriers. Similar results were obtained with volumes
of both total PA and PA at moderate to vigorous inten-
sity. This FC profile was correlated with varying
Fig. 1 FC-st results in the theta band. In dark blue, marked as mθ, the brain region whose functional connectivity strength (FC-st) was found
inversely correlated with total physical activity (TPA) is displayed. On the right, the scatter plot shows the correlation between mθFC-st and TPA
computed with the whole sample (gray), APOE ε4 carriers (orange), and non-carriers (green)
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beneficial effects in AD-related features in both APOE
ε4 carriers and non-carriers. However, these favorable
associations differed according to AD genetic risk.
More specifically, we found a relationship between
region-specific decrease in FC-st and greater total
GM volumes, greater integrity of the uncinate fascic-
ulus, higher episodic and working memory scores,
and reduced anxiety levels across the whole sample.
In the APOE ε4 non-carriers only, network profile
correlated with enhanced episodic and working mem-
ory, cognitive skills known to be affected early in the
course of AD. In contrast, in APOE ε4 carriers, left
temporal hypoconnectivity was associated with more
preserved brain structure, particularly in areas that
are more vulnerable to AD pathology (hippocampus,
precuneus, amygdala, and uncinate tract). Figure 3
summarizes these results.
Our finding that PA is associated with reduced tem-
poral lobe hypersynchrony in healthy older adults (even
in individuals at greater genetic risk for AD) is note-
worthy, considering that AD has been traditionally de-
scribed as a disconnection syndrome [39]. However,
recent evidence is building on the idea that preclinical
AD is characterized by a dual neurophysiological profile.
Through MEG, it has been discovered that in subjective
memory decline and mild cognitive impairment, a state
of hypersynchrony precedes the well-known phase of
hypoconnectivity [18–22]. A closer look at these individ-
uals’ brain microstructure provides a plausible explan-
ation for these chronological changes. At the very early
Fig. 2 FC-st results in the delta band. a In dark blue, marked as mδ, the brain region whose functional connectivity strength (FC-st) was found
inversely correlated with total physical activity (TPA) is displayed. In light blue, those regions, marked as s1δ and s2δ, whose FC with mδ was
found to inversely correlate with TPA are depicted. On the right, the scatter plot shows the correlation between mδ FC-st and TPA computed
with the whole sample (gray), APOE ε4 carriers (orange), and non-carriers (green). b Seed 1 results (s1δ). Purple line represents the significant FC
link whose value is included in the correlation analysis. The correlation between mδ <−> s1δ FC and TPA is shown on the right. c Seed 2 results
(s2δ). Purple line represents the significant FC link whose value is included in the correlation analysis. The correlation between mδ <−> s2δ FC
and physical activity is shown on the right
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silent stages of AD pathology, inhibitory neurons are
lost, mainly in middle temporal regions [13, 14]. Such
loss of inhibitory synapses leads to a state of brain hy-
perexcitability and hypersynchrony, which can be
tracked through MEG [15]. Sustained hyperactivation
elicits neurotoxic effects and increased release of amyl-
oid (which ultimately lead to neuronal damage [16, 17]).
As a result, extensive brain atrophy and generalized
hypoconnectivity are evident features by the time AD
clinical symptomatology arises [40].
It is interesting that it was the left temporal lobe which ex-
hibited significant results, since decreased synchronization
in AD, already at the dementia stage, seems to mainly affect
the left hemisphere [41]. On the other hand, both normal
aging and AD brain activity presents a marked “slowness,”
this is an increase in power in low frequency bands (delta
and theta) [42]. In fact, increases in delta connectivity had
already been described as a pathological sign in other clinical
conditions, as well as decreases upon cognitive recovery
[43]. It is possible then that since low frequency rhythms are
more associated with brain neurophysiological health, PA
could exert its beneficial effect by affecting these rhythms
specifically. Conversely, although there are not many func-
tional connectivity studies that could provide an explanation
on why physical activity affects those frequency bands in
particular, power spectrum studies suggest that during an
acute bout of exercise, activity in the theta band is enhanced.
Such increase in theta power is believed to serve a cognitive
function, as physical activity is evolutionary associated with
increases in cognitive demands [44]. This effect is usually re-
versed immediately after the physical activity bout ceases
[45, 46]. This phenomenon could be related to the
diminished FC-st within the theta band that we find in
active individuals at rest.
In an attempt to understand the meaning of our FC
results, we also studied the association between the ob-
served brain activity patterns and cognitive/emotional
functioning, brain volumes, and white matter integrity:
within these analyses, differences between APOE ε4 car-
riers and non-carriers are evident. Previous literature of-
fers mixed results with regard to whether APOE ε4
carriers or non-carriers gain the greatest benefit from
PA engagement. This inconsistent literature may be a re-
sult of the utilization of varying PA measurements
(questionnaires, fitness measures, and PA interventions)
and different outcomes (AD risk, cognitive scores, or
brain activity/structure), conducted in samples of differ-
ent characteristics (in terms of age, AD risk, and cogni-
tive status). In the current study, we examined the effect
of objectively measured PA on a wide range of AD
markers employing a sample of cognitively healthy
APOE ε4 carriers and non-carriers properly matched on
an extensive list of potential confounders.
While measures of different brain volumes correlated
with FC-st in the ε4 carrier group, these associations did
not exist in ε4 non-carriers. The same pattern arose
when looking at the integrity of the uncinate tract. It is
important to highlight that these are all brain structures
that are particularly vulnerable to AD pathology. Since
this is a sample of cognitively healthy participants, our
results could be better understood if we consider that in-
dividuals at increased genetic risk already present greater
variability in GM and WM state of preservation. There-
fore, we could assume that there is more room for PA to
Table 3 Seed-based analyses
Seed mδTPA mδMVPA
Cluster Anterior (s1δTPA) Posterior (s2δTPA) Anterior (s1δMVPA) Posterior (s2δMVPA)
ROIs Left cingulate gyrus, anterior
part (10.5%)
Left calcarine fissure and surrounding
cortex (20%)
Left middle frontal gyrus
(11.8%)
Left calcarine fissure and surrounding
cortex (20%)
Left precentral gyrus (9.4%) Left cuneus (9.1%)
Left cingulate gyrus, medial
part (50%)
Left lingual gyrus (7.1%) Left superior frontal gyrus
(18.5%)
Left lingual gyrus (7.1%)
Left middle frontal gyrus
(17.6%)




Right calcarine fissure and surrounding
cortex (16.7%)
Left paracentral lobule (33.3%) Right lingual gyrus (22.2%)
Left precentral gyrus (15.6%) Right cuneus (30.8%)
Left superior frontal gyrus
(11.1%)
Right lingual gyrus (33.3%)
Left supplementary motor
area (50%)
Right middle occipital lobe (17.6%)
Left superior frontal gyrus,
medial (5.9%)
Right middle temporal gyrus (5.4%)
Each main cluster (mθTPA, mδTPA, and mδMVPA) whose functional connectivity strength (FC-st) was significantly correlated with PA was used as a seed in a
seed-based analysis. Clusters in the delta band (mδTPA and mδMVPA) presented lower FC to two extra clusters each (s1δTPA, s2δTPA, s1δMVPA, and s2δMVPA).
The regions of interest (ROIs) that are comprised in each additional cluster are presented. The percentage of each ROI captured by each cluster is presented
in brackets
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counterbalance early neuropathological signs within this
group. This is consistent with previous studies that dem-
onstrate the effect of PA on brain pathology is most pre-
dominant among ε4 carriers [7, 47, 48].
Contrary to our aforementioned findings within APOE
ε4 carriers, we observed a relationship between de-
creased FC and greater scores in specific measures of
episodic and working memory, but only among APOE ε4
non-carriers. Most studies investigating the relationship
between AD incidence and PA have concluded that only
APOE ε4 non-carriers benefit from reduced AD risk at
greater levels of PA [9, 49, 50], although there are some
exceptions [51, 52]. Presently, AD diagnosis is based on
clinical progression and cognitive status. Therefore, our
finding that the profile of FC associated with PA only
predicts cognitive functioning among APOE ε4 non-
carriers is somewhat consistent with previous research.
Finally, across the whole sample and APOE ε4 carriers,
we found a positive correlation between greater FC-st
and higher anxiety. In previous studies, anxiety has been
identified as a marker of conversion from preclinical AD
to AD [53, 54]. In addition, higher levels of anxiety are
related to greater temporal lobe atrophy [55]. Hence,
our results demonstrate that PA-associated reduced FC-
st is also associated with lower anxiety levels and greater
temporal lobe volumes.
PA has been widely studied as a protective ally against
AD. Our study sheds light on the potential mechanisms
through which PA could exert its action. According to
the neurogenic reserve hypothesis, throughout evolution
acute bouts of PA were linked to an increased likelihood
of a potential cognitive challenge [56, 57]. As hunter-
gatherers, going through long distances relied on im-
proved spatial orientation, memory, and executive func-
tions. Locomotion would signal the brain such increase
in cognitive demands. In response, the reserve of neur-
onal precursor cells would grow. In the presence of cog-
nitive stimulation, new neurons would maturate,
differentiate, and migrate. Multiple sources of evidence
support the postulate that PA promotes synaptogenesis
and neurogenesis, mainly within the hippocampal net-
work [58, 59]. Newborn granule cells do not produce hy-
peractivation but rather present sparse activity during
learning [60]. Such mechanisms could explain the de-
creased temporal FC profile that we detect in older
adults who regularly engage in greater levels of PA. But
most importantly, they could explain why PA is one the
most relevant modifiable protective factor against AD.
Indeed, Raicheln and Alexander hypothesize that 2 mil-
lion years ago, PA was able to counterbalance the detri-
mental effects of APOE ε4, when our ancestors carried
two copies of this risk allele [61]. However, although in
this study we report that the association between PA
and FC-st is associated to beneficial effects in both ε4
carriers and non-carriers, it remains possible that the
underlying mechanisms differ based on AD genetic risk.
The results observed in the current study provide a
more comprehensive picture of the relationship between
Table 4 Correlation analyses
Whole sample Carriers Non-carriers
mθTPA mδTPA mδMVPA mθTPA mδTPA mδMVPA mθTPA mδTPA mδMVPA
Rho p Rho p Rho p Rho p Rho p Rho p Rho p Rho p Rho p
Forward digits − 0.20 0.03 − 0.18 0.061 − 0.20 0.04 − 0.30 0.09 − 0.08 0.66 − 0.04 0.84 − 0.17 0.14 − 0.23 0.05 − 0.28 0.01
Reverse digits − 0.23 0.02 − 0.21 0.03 − 0.22 0.03 − 0.29 0.11 − 0.23 0.20 − 0.22 0.23 − 0.23 0.05 − 0.22 0.06 − 0.22 0.06
Logical mem. units − 0.00 0.96 − 0.00 0.99 − 0.03 0.78 − 0.11 0.54 − 0.16 0.40 − 0.12 0.51 0.05 0.65 0.09 0.47 0.06 0.63
Logical
mem. gist
− 0.18 0.07 − 0.27 0.01 − 0.23 0.02 − 0.09 0.62 − 0.13 0.51 − 0.09 0.66 − 0.20 0.10 − 0.34 0.01 − 0.30 0.01
Anxiety 0.29 < 0.01 0.22 0.03 0.2 0.05 0.46 0.01 0.28 0.15 0.29 0.13 0.20 0.09 0.19 0.13 0.16 0.18
Depression 0.08 0.423 0.08 0.43 0.079 0.44 − 0.04 0.84 − 0.06 0.72 − 0.11 0.54 0.14 0.25 0.17 0.17 0.20 0.10
Total GM − 0.27 0.01 − 0.29 < 0.01 − 0.29 < 0.01 − 0.39 0.03 − 0.44 0.01 − 0.43 0.02 − 0.23 0.05 − 0.23 0.05 − 0.23 0.05
Amygdala − 0.28 < 0.01 − 0.27 < 0.01 − 0.27 < 0.01 − 0.33 0.07 − 0.41 0.02 − 0.39 0.03 − 0.25 0.03 − 0.21 0.08 − 0.21 0.07
Hippocampus − 0.26 0.01 − 0.27 < 0.01 − 0.28 < 0.01 − 0.50 < 0.01 − 0.47 0.01 − 0.42 0.02 − 0.16 0.18 − 0.17 0.15 − 0.20 0.08
Precuneus − 0.14 0.15 − 0.20 0.04 − 0.21 0.03 − 0.15 0.41 − 0.42 0.02 − 0.42 0.02 − 0.11 0.35 − 0.10 0.42 − 0.10 0.41
Global FA − 0.03 0.72 − 0.08 0.43 − 0.04 0.69 − 0.18 0.33 − 0.16 0.38 − 0.11 0.56 − 0.00 0.97 − 0.04 0.73 − 0.00 0.98
Uncinate − 0.24 0.02 − 0.18 0.07 − 0.14 0.16 − 0.61 < 0.01 − 0.44 0.01 − 0.39 0.03 − 0.07 0.58 − 0.07 0.59 − 0.01 0.91
Parahippocampus − 0.00 0.96 − 0.07 0.49 − 0.03 0.76 − 0.17 0.37 − 0.30 0.10 − 0.22 0.23 0.05 0.68 0.03 0.77 0.07 0.55
Results for Spearman’s correlation analyses between mean FC-st of each main cluster (mθTPA, mδTPA, and mδMVPA) and a series of AD markers (rho
and p values) are shown. The list of variables includes the following: working memory (Forward and Reverse Digit Span—forward and reverse digits);
episodic memory (Logical Memory II—delayed recall; for units and gist—logical mem. units and gist); anxiety (Goldberg’s test); depression (Geriatric
Depression Scale); total gray matter volume (GM, in cubic millimeter); hippocampus, amygdala, and precuneus volumes (left plus right, in cubic
millimeter); global fractional anisotropy (FA); and uncinate and parahippocampal fasciculus fractional anisotropy (left and right weighted arithmetic
mean). Outcomes that were significant for α < 0.05 and FDR q = 0.1 are bolded
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PA, APOE, and AD pathology, compared with previously
conducted studies. Our findings help strengthen the un-
derstanding of the complex dynamics that underpin the
varying outcomes observed in previous studies. Although
the age range in this sample was fairly broad, the mean
age was still quite low to study the effects of advanced
aging or prodromal AD. Therefore, it is possible that we
missed out on certain effects that might only appear at
later stages of life. Follow-up studies are required to deter-
mine how the FC profiles identified within this study are
associated with pathological progression and cognitive
change among, at-present, cognitively healthy older adults.
Also, future studies should include a group of APOE ε4
homozygotes, since our sample size did not allow us to in-
corporate that comparison. Additionally, it would be inter-
esting to see how diverse PA parameters, such as the type
of activity or frequency of practice, affect certain markers
of the disease. This information could be useful in the
elaboration of lifestyle guidelines aiming to promote brain
health. Unfortunately, such measures were not available
from this cohort. In addition, it would be useful to include
specific AD biomarkers to better characterize brain health
in individuals at risk, instead of relying solely in genetic
risk factors to identify individuals at greater risk of devel-
oping dementia.
Conclusions
Altogether, our study offers novel insights into this field,
clarifying some of the specific mechanisms that underlie
the beneficial effect of PA in APOE ε4 carriers and non-
carriers. It enables the integration of previous publica-
tions and leads the way to future findings. Previous lit-
erature offered apparently inconsistent results, but our
study suggests that the specific brain health outcomes
considered could be differently affected by PA in ε4 car-
riers and non-carriers. Nevertheless, we were able to de-
scribe an association between PA and decreased
temporal lobe hypersynchrony across the whole sample
that highlights the need to design new policies that fos-
ter PA among older adults, including those more vulner-
able to develop AD.
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Fig. 3 Proposed mechanism for physical activity-induced beneficial effects
on brain health in APOE ε4 carriers and non-carriers. Physical activity (PA) is
associated with decreased functional connectivity (FC) both in APOE ε4
carriers and non-carriers. We propose that this relationship could be
mediated by a PA-induced increase in neurogenesis and synaptogenesis.
Such processes could in turn prevent the loss of inhibitory synapses that
has been identified to cause hyperexcitability in temporal regions in
prodromal Alzheimer’s disease (AD). Interestingly, this decrease in FC
manifests differently according to AD genetic risk. In ε4 carriers, this profile
is linked to reduced anxiety and preserved brain structure. Conversely, in ε4
non-carriers, it is associated with enhanced cognition. One possibility
behind this pattern of results could be that ε4 carriers were at higher risk of
neuronal damage, which in normal aging would appear later. Therefore, at
the specific time when we are taking these measurements, PA has more
room to exert its beneficial effect on brain structure in ε4 carriers, while in
non-carriers, at lower risk for neuropathological burden, it is associated with
improved cognitive functioning. Hence, it remains plausible that at older
ages, PA could also relate to greater structural integrity. However, we
cannot rule out the possibility that PA affected ε4 carriers and non-carriers
through different mechanisms
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